PMC:7796052 / 957-1253 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"47","span":{"begin":13,"end":21},"obj":"Species"},{"id":"48","span":{"begin":36,"end":46},"obj":"Species"},{"id":"54","span":{"begin":22,"end":30},"obj":"Disease"},{"id":"55","span":{"begin":92,"end":101},"obj":"Disease"},{"id":"56","span":{"begin":129,"end":138},"obj":"Disease"},{"id":"57","span":{"begin":140,"end":175},"obj":"Disease"},{"id":"58","span":{"begin":177,"end":181},"obj":"Disease"},{"id":"59","span":{"begin":184,"end":199},"obj":"Disease"},{"id":"60","span":{"begin":201,"end":206},"obj":"Disease"},{"id":"61","span":{"begin":208,"end":226},"obj":"Disease"},{"id":"62","span":{"begin":228,"end":251},"obj":"Disease"},{"id":"63","span":{"begin":256,"end":289},"obj":"Disease"}],"attributes":[{"id":"A47","pred":"tao:has_database_id","subj":"47","obj":"Tax:9606"},{"id":"A48","pred":"tao:has_database_id","subj":"48","obj":"Tax:2697049"},{"id":"A54","pred":"tao:has_database_id","subj":"54","obj":"MESH:D007239"},{"id":"A55","pred":"tao:has_database_id","subj":"55","obj":"MESH:D011014"},{"id":"A56","pred":"tao:has_database_id","subj":"56","obj":"MESH:D000860"},{"id":"A57","pred":"tao:has_database_id","subj":"57","obj":"MESH:D012128"},{"id":"A58","pred":"tao:has_database_id","subj":"58","obj":"MESH:D012128"},{"id":"A59","pred":"tao:has_database_id","subj":"59","obj":"MESH:D011654"},{"id":"A60","pred":"tao:has_database_id","subj":"60","obj":"MESH:D012769"},{"id":"A61","pred":"tao:has_database_id","subj":"61","obj":"MESH:D000138"},{"id":"A62","pred":"tao:has_database_id","subj":"62","obj":"MESH:D001778"},{"id":"A63","pred":"tao:has_database_id","subj":"63","obj":"MESH:D009102"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"About 20% of patients infected with SARS-Cov-2 develop respiratory complications, including pneumonia, that may evolve to severe hypoxemia, acute respiratory distress syndrome (ARDS), pulmonary edema, shock, metabolic acidosis, coagulation dysfunction and multiple organ functional failure [1,2]."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T2","span":{"begin":92,"end":101},"obj":"Phenotype"},{"id":"T3","span":{"begin":129,"end":138},"obj":"Phenotype"},{"id":"T4","span":{"begin":146,"end":166},"obj":"Phenotype"},{"id":"T5","span":{"begin":184,"end":199},"obj":"Phenotype"},{"id":"T6","span":{"begin":201,"end":206},"obj":"Phenotype"},{"id":"T7","span":{"begin":208,"end":226},"obj":"Phenotype"}],"attributes":[{"id":"A2","pred":"hp_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/HP_0002090"},{"id":"A3","pred":"hp_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/HP_0012418"},{"id":"A4","pred":"hp_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/HP_0002098"},{"id":"A5","pred":"hp_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/HP_0100598"},{"id":"A6","pred":"hp_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/HP_0031273"},{"id":"A7","pred":"hp_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/HP_0001942"}],"text":"About 20% of patients infected with SARS-Cov-2 develop respiratory complications, including pneumonia, that may evolve to severe hypoxemia, acute respiratory distress syndrome (ARDS), pulmonary edema, shock, metabolic acidosis, coagulation dysfunction and multiple organ functional failure [1,2]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T10","span":{"begin":0,"end":296},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"About 20% of patients infected with SARS-Cov-2 develop respiratory complications, including pneumonia, that may evolve to severe hypoxemia, acute respiratory distress syndrome (ARDS), pulmonary edema, shock, metabolic acidosis, coagulation dysfunction and multiple organ functional failure [1,2]."}